Chengdu, China

Dexi Jiang

This inventor holds 1 USPTO granted patent. Top assignee: Sichuan Yuandashuyang Phamaceutical Co., Ltd. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Dexi Jiang in Pathogen Inactivation

Introduction

Dexi Jiang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of microbiology, particularly in the area of pathogen inactivation. His innovative methods aim to enhance the safety and efficacy of bio-products.

Latest Patents

Dexi Jiang holds a patent for a "Method for terminal inactivation of pathogenic microorganisms." This invention outlines a process that includes vacuum freeze-drying a bio-product packaged in a container, followed by the introduction of gas and sealing to obtain the end product. The method also involves dry-heating for effective inactivation. This approach is particularly effective against non-lipid enveloped viruses, including parvoviruses, and addresses the limitations of traditional dry-heating methods.

Career Highlights

Dexi Jiang is associated with Sichuan Yuandashuyang Pharmaceutical Co., Ltd. His work at this company has allowed him to focus on developing innovative solutions for pathogen inactivation. His expertise in this area has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Dexi Jiang has collaborated with colleagues such as Shuguang Ran and Jun Chen. Their combined efforts contribute to advancing research and development in pathogen inactivation techniques.

Conclusion

Dexi Jiang's innovative methods for pathogen inactivation represent a significant advancement in microbiological safety. His contributions are essential for improving the efficacy of bio-products and ensuring public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…